Progyny (Progyny) GF Value : $69.64 (As of Apr. 26, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Progyny GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-04-26), Progyny's share price is $32.04. Progyny's GF Value is $69.64. Therefore, Progyny's Price-to-GF-Value for today is 0.46.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Progyny is Significantly Undervalued.

Progyny (NAS:PGNY) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Progyny's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	32.04	/	69.64
	=	0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Progyny GF Value Related Terms

Thank you for viewing the detailed overview of Progyny's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Progyny (Progyny) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Progyny Inc (NAS:PGNY) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

1359 Broadway, New York, NY, USA, 10018

Website

https://www.progyny.com

Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.

Executives

David J Schlanger	director, officer: Executive Chairman	C/O PROGYNY, INC., 1359 BROADWAY, 2ND FLOOR, NEW YORK NY 10018
Michael E Sturmer	officer: President	48 LEDYARD RD, WEST HARTFORD CT 06117
Mark S. Livingston	officer: Chief Financial Officer	C/O PROGYNY, INC., 1359 BROADWAY, 2ND FL, NEW YORK NY 10018
Kevin K Gordon	director	155 S LIMERICK RD, LIMERICK PA 19468
Tpg Gp A, Llc	10 percent owner	301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Peter Anevski	officer: Chief Executive Officer	C/O PROGYNY, INC., 1359 BROADWAY, 2ND FLOOR, NEW YORK NY 10018
Cheryl Scott	director	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Norman Payson	director	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Allison Swartz	officer: EVP, GC	C/O PROGYNY, INC., 1359 BROADWAY, NEW YORK NY 10018
Lloyd H Dean	director	185 BERRY STREET, SUITE 300, SAN FRANCISCO CA 94107
Monice Barbero	officer: EVP, GC and Secretary	C/O PROGYNY, INC., 1359 BROADWAY, NEW YORK NY 10018
Jon Winkelried	10 percent owner	C/O GOLDMAN, SACHS & CO., 85 BROAD STREET, NEW YORK NY 10004
Beth C Seidenberg	director
Jennifer Bealer	officer: EVP, General Counsel	C/O PROGYNY, INC., 245 5TH AVENUE, NEW YORK NY 10016
Malissia Clinton	director	333 THREE D SYSTEMS CIRCLE, ROCK HILL SC 29730